全体要約
アジア太平洋地域は、2024年から2029年の予測期間中に最も高い成長率を示すと期待されています。マウスモデルに基づく前臨床研究の普及や、急成長する医療分野がこの成長を後押ししています。製薬およびバイオテクノロジー企業からの資金提供や投資の増加も、アジア太平洋地域のマウスモデル市場の成長を促進する要因です。慢性疾患の増加に伴い、信頼性の高い動物モデルへの需要が高まっております。
関連する質問
22億USD（2029年）
8.1%（2024年から2029年）
Charles River Laboratories, Inotiv, THE JACKSON LABORATORY, GemPharmatech, Cyanogen, Shanghai Model Organisms Center, Inc., JSR Corporation, Biocytogen, TRANS GENIC INC., Ozgene Pty Ltd., Taconic Biosciences, Inc., TransCure bioServices, Harbour BioMed, Marshall BioResources, genOway, Vivo Bio Tech Ltd., ingenious targeting laboratory, Janvier Labs, Applied StemCell, Creative Animodel, JOINN Laboratories Co., Ltd., Creative Biolabs, Crescendo Biologics, Aragen Life Sciences, PolyGene
薬剤発見と開発のための研究開発努力, 個別化医療への成長する焦点, 前臨床研究でのマウスモデルの採用の増加
概要
「モデルタイプセグメントは2023年においてモデルタイプとサービスの中で最大のシェアを占めました。」
2023年には、モデルタイプセグメントが全球マウスモデル市場におけるモデルタイプおよびサービスセグメントの中で最大のシェアを占めました。マウスの遺伝的類似性や、マウスモデルが人間の病気の研究、新薬や治療法のテスト、生物学的プロセスの理解において重要な役割を果たしていることなどの要因が、この市場の成長を促進しています。
「アジア太平洋地域は、2024年から2029年の予測期間において、マウスモデル市場で最も高いCAGRで成長しています。」
アジア太平洋地域は、予測期間中に最も高い成長率を示すと期待されています。マウスモデルに基づく前臨床研究の採用の増加や急成長するヘルスケアセクターなどのさまざまな要因が、地域のマウスモデル市場の成長を促進しています。
製薬およびバイオテクノロジー企業からの資金提供と投資の増加が、アジア太平洋地域におけるマウスモデル市場の成長を促進すると予想されています。この地域は生物医学研究や医薬品開発に投資を続けており、前臨床研究や薬剤発見の努力を支えるためのマウスモデルの需要が高まっています。また、アジア太平洋諸国における慢性疾患の増加が、病気のメカニズムをよりよく理解し、潜在的な治療法を試験するための信頼できる動物モデルの必要性を刺激しています。
この報告書のために実施された主要なインタビューは以下のように分類できます。
• 回答者別：供給側 70% と需要側 30%
• 役職別：C級役員 - 55%、ディレクター級 - 20%、その他 - 25%
地域別: 北米 -45%、ヨーロッパ -20%、アジア太平洋 -20%、ラテンアメリカ -10%、中東 -3%、アフリカ -2%
レポートに記載されている企業のリスト：
チャールズリバーラボラトリーズ（米国）
イノティブ（アメリカ）
・ジャクソン研究所 (アメリカ)
・ジェムファーマテック（中国）
シアノジェン (アメリカ)
上海モデル生物センター株式会社 (中国)
JSR株式会社（日本）
・バイオサイオジェン（中国）
トランスジェニック株式会社 (日本)
オズジーン Pty Ltd. (オーストラリア)
タコニックバイオサイエンシズ社（アメリカ）
トランスキュアバイオサービス（フランス）
ハーバー・バイオメド (中国)
マシャル・バイオリソース（米国）
・genOway（フランス）
ヴィーボバイオテック株式会社（インド）
・インジェニアス・ターゲティング・ラボ（米国）
・ジャンヴィエールラボ（フランス）
アプライド・ステムセル（米国）
クリエイティブアニモデル (米国)
JOINNラボラトリーズ株式会社（中国）
クリエイティブバイオラボ（アメリカ）
クレッシェンド・バイオロジクス（英国）
アラゲンライフサイエンシズ（インド）
ポリジーン（スイス）
調査範囲:
この調査報告書は、マウスモデル市場をモデルタイプとサービス（モデルタイプおよびサービス）、技術（CRISPR/Cas9、マイクロ注射、胚幹細胞注射、核移植、その他の技術）、治療領域（腫瘍学、神経学、代謝疾患、免疫学、心血管疾患、その他の疾患）、応用（薬の発見と開発、研究応用、個別化医療）、最終ユーザー（製薬およびバイオテクノロジー企業、学術および研究機関、CROおよびCDMO）、地域別（北アメリカ、ヨーロッパ、アジア太平洋、ラテンアメリカ、中東、アフリカ）に分類しています。この報告書は、マウスモデル市場の成長に影響を与える重要な要因についての詳細な情報を提供しており、ドライバー、トレンド、課題、機会が含まれます。また、主要な業界プレーヤーの徹底的な分析が行われており、彼らのビジネスプロファイル、製品/サービス、主要戦略、コラボレーション、パートナーシップ、契約についての洞察を提供。さらに、この報告書は、マウスモデル市場における新製品の発売、合併、買収などの最近の開発も網羅しています。
レポート購入の主なメリット：
この報告書は、市場のリーダーや新規参入者に、全体のマウスモデル市場およびそのサブセグメントの収益数字の最も近い推定値を提供することで役立ちます。また、ステークホルダーが競争環境をよりよく理解し、自社のポジショニングを改善し、適切な市場投入戦略を策定するための洞察を得るのにも役立ちます。この報告書は、ステークホルダーが市場の動向を理解し、主要な市場ドライバー、制約、機会、課題に関する情報を提供します。
レポートは以下のポイントに関する洞察を提供します：
市場の成長に影響を与える主要な要因（前臨床研究におけるマウスモデルの遺伝的および生理的多様性、マウス臨床試験（MCT）の需要増加、腫瘍学における個別化医療への需要の高まり、遺伝子工学の進展）、制約（3Dの導入、倫理的懸念および規制制約）、機会（バイオメディカル研究におけるCRISPRの活用、特定の疾患モデルの需要増加）、および課題（代替動物試験方法の開発、遺伝的および表現型の変動性）。
• 製品開発/革新：マウスモデル市場における新しく発売された製品/サービスに関する詳細な洞察
• 市場開発：収益性の高い市場に関する包括的な情報 - レポートはさまざまな地域での市場を分析しています。
• 市場の多様化：マウスモデル市場における新製品/サービス、未開拓の地理、最近の動向、及び投資に関する詳細な情報
• 競争評価: チャールズ・リバー・ラボラトリーズ（米国）、イノティブ（米国）、ザ・ジャクソン・ラボラトリー（米国）、ジェムファーマテック（中国）、サイアゲン（米国）、上海モデル生物センター（中国）、JSR株式会社（日本）、バイオサイオジェン（中国）、トランスジェニック株式会社（日本）、オージーン・プライベート・リミテッド（オーストラリア）、タコニック・バイオサイエンシズ（米国）、トランスキュア・バイオサービス（フランス）、ハーバー・バイオメッド（中国）、マーシャル・バイオリソース（米国）、ジェノウェイ（フランス）、ビボ・バイオテック・リミテッド（インド）、インジェニアス・ターゲティング・ラボラトリー（米国）、ジャンビエール・ラボ（フランス）、アプライド・ステムセル（米国）、クリエイティブ・アニモデル（米国）、JOINNラボラトリーズ株式会社（中国）、クリエイティブ・バイオラボ（米国）、クレッシェンド・バイオロジクス（英国）、アラゲン・ライフサイエンス（インド）、およびポリジーン（スイス）など、市場の中で。
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 イントロダクション 51
1.1 調査の目的 51
1.2 市場の定義 51
1.2.1 包含・除外事項 52
1.3 市場範囲 53
1.3.1 市場セグメンテーション 53
1.3.2 対象地域 54
1.4 対象年 54
1.5 通貨 55
1.6 ステークホルダー 55
1.7 制約 55
1.8 変化のサマリー 56
1.9 リセッション時のインパクト 56
2 調査手法 57
2.1 リサーチデータ 57
2.1.1 二次データ 58
2.1.2 一次データ 58
2.2 市場予測手法 59
2.2.1 ボトムアップアプローチ 60
2.2.2 一次エキスパート考察 62
2.3 トップダウンアプローチ 62
2.4 成長予測 64
2.5 市場の内訳とデータのトライアンギュレーション 65
2.6 調査の前提 66
2.7 市場予測 66
2.8 リスク分析 67
2.9 リセッション時のインパクト分析 67
3 エグゼクティブサマリー 68
4 更なる考察 72
4.1 マウスモデル市場の概要 72
4.2 アジア太平洋地域：マウスモデル市場：モデルタイプ・サービス別（2023年） 73
4.3 マウスモデル市場、地理的側面での成長機会 74
4.4 マウスモデル市場シェア、エンドユーザー別 74
5 市場概要 75
5.1 イントロダクション 75
5.2 市場ダイナミクス 75
5.2.1 促進要因 76
- 5.2.1.1 前臨床試験におけるマウスモデルの高い採用率 76
- 5.2.1.2 マウス臨床試験（MCT）の需要の増加 77
- 5.2.1.3 がん治療における個別化医療への嗜好の高まり 78
- 5.2.1.4 遺伝子工学の進歩 78
5.2.2 抑制要因 79
- 5.2.2.1 3Dプリントモデルの紹介 79
- 5.2.2.2 倫理的懸念と規制上の制限 79
5.2.3 市場機会 80
- 5.2.3.1 バイオメディカル研究におけるCRISPRの活用について 80
- 5.2.3.2 疾患特異的モデルへの需要の高まり 80
5.2.4 課題 80
- 5.2.4.1 動物実験代替法の開発 80
- 5.2.4.2 遺伝的・表現型的変異性 81
5.3 マウスモデル市場の概観 81
5.3.1 マウスモデルの歴史 81
5.3.2 マウスモデル生成プロセス 81
5.3.3 マウスモデル開発のテクニック 82
5.3.4 技術進歩 83
5.3.5 マウスモデル開発における考慮点 84
5.4 サプライチェーン分析 84
5.5 バリューチェーン分析 85
5.6 価格分析 87
5.6.1 平均販売価格トレンド分析 87
5.7 エコシステム分析 88
5.7.1 マウスモデルベンダー 89
5.7.2 マウスモデル・サービス・ベンダー 89
5.7.3 マウスモデルエンドユーザー 90
5.7.4 規制機関 91
5.8 顧客事業にインパクトのあるトレンド/ディスラプション 91
5.9 特許分析 92
5.9.1 調査手法 92
5.9.2 特許出願件数、文書タイプ別、2014-2024年 93
5.9.3 イノベーションと特許出願 93
5.9.4 上位の候補 94
5.10 主要なカンファレンスイベント 96
5.10.1 マウスモデル市場：主要会議・イベント（2024-2025年） 96
5.11 規制の概観 97
5.11.1 規制分析 97
- 5.11.1.1 北米 97
- 5.11.1.2 ヨーロッパ 98
- 5.11.1.3 中国 99
- 5.11.1.4 日本 100
- 5.11.1.5 インド 100
- 5.11.1.6 オーストラリア 101
- 5.11.1.7 ブラジル 101
5.11.2 規制当局、政府機関、その他組織 101
5.12 ポーターのファイブフォース分析 106
5.12.1 新規参入の脅威 106
5.12.2 代替品の脅威 107
5.12.3 買い手の交渉力 107
5.12.4 サプライヤーの交渉力 107
5.12.5 競合・競争状況の激しさ 107
5.13 主なステークホルダーと購入基準 108
5.13.1 購買プロセスにおける主要ステークホルダー 108
5.13.2 購買プロセスにおけるステークホルダーの役割 109
5.13.3 マウスモデルの購入基準 109
6 マウスモデル市場、モデルタイプおよびサービス別 111
6.1 イントロダクション 112
6.2 モデルタイプ 112
6.2.1 インベーダーマウス 115
- 6.2.1.1 研究用途での高い利用が市場を促進 115
6.2.2 遺伝子組換えマウス 118
6.2.3 ハイブリッド／コンジェニックマウス 121
- 6.2.3.1 生物医学研究への関心の高まりが需要を押し上げる 121
6.2.4 アウトレットマウス 124
- 6.2.4.1 市場の成長を支える遺伝的多様性のメリット 124
6.3 サービス 127
6.3.1 ブリーディングサービス 130
- 6.3.1.1 特定の研究用途にモデルをカスタマイズして需要を高める 130
6.3.2 クライオプレザベーションサービス 133
6.3.3 再活性化サービス 136
- 6.3.3.1 厳しい品質保証基準で市場に燃料を供給 136
6.3.4 検疫サービス 139
- 6.3.4.1 無菌マウスへの需要の高まりが市場成長を支える 139
6.3.5 その他サービス 143
7 マウスモデルの市場、技術別 147
7.1 イントロダクション 148
7.2 CRISPR/CAS9 148
7.3 マイクロインジェクション 151
7.3.1 低毒性と高い成功率が市場を促進 151
7.4 胚性幹細胞注入法 154
7.5 核転送 157
7.5.1 同一マウスを製造できる可能性が市場を牽引 157
7.6 その他の技術 160
8 マウスモデルの市場、治療エリア別 164
8.1 イントロダクション 165
8.2 オンコロジー 165
8.2.1 オンコロジー治療開発への注目の高まりが市場を後押し 165
8.3 代謝性疾患 169
8.3.1 糖尿病の有病率増加が市場を牽引 169
8.4 免疫学 172
8.4.1 免疫疾患の臨床研究の増加が市場を後押し 172
8.5 神経学 175
8.6 循環器系疾患 178
8.6.1 CVDの標的治療への関心の高まりが需要を押し上げる 178
8.7 その他治療エリア 181
9 マウスモデルの市場、用途別 185
9.1 イントロダクション 186
9.2 ドラッグディスカバリー＆デベロップメント 186
9.2.1 臨床試験数の増加が市場を牽引 186
9.3 リサーチアプリケーション 189
9.3.1 がん研究費の増加が需要を押し上げる 189
9.4 パーソナライズド医療 192
9.4.1 がん治療薬への嗜好の高まりが市場を後押し 192
10 マウスモデルの市場、エンドユーザー別 196
10.1 イントロダクション 197
10.2 製薬会社・バイオテクノロジー企業 197
10.2.1 RISING EXPENDITURE ON R&D FOR DRUG DEVELOPMENT TO BOOST DEMAND 197
10.3 学術・研究機関 201
10.4 受託研究機関および受託開発・製造機関 204
10.4.1 創薬アウトソーシングの増加が市場を牽引 204
11 マウスモデルの市場、地域別 207
11.1 イントロダクション 208
11.2 北米 208
11.2.1 北米：リセッション時のインパクト 208
11.2.2 米国 213
11.2.3 カナダ 216
- 11.2.3.1 幹細胞研究活動の成長が市場成長を支える 216
11.3 ヨーロッパ 219
11.3.1 ヨーロッパ：リセッション時のインパクト 219
11.3.2 ドイツ 222
- 11.3.2.1 成長するバイオテクノロジー産業が市場を牽引 222
11.3.3 英国 225
- 11.3.3.1 がん研究への関心の高まりが市場を後押し 225
11.3.4 フランス 228
- 11.3.4.1 成長を促進するプロテオミクスとゲノミクスへの投資の増加 228
11.3.5 イタリア 230
- 11.3.5.1 製薬・バイオテクノロジー産業の成長が市場を牽引 230
11.3.6 スペイン 233
- 11.3.6.1 市場成長を支える豊富な研究開発パイプライン 233
11.3.7 その他のヨーロッパ 236
11.4 アジア太平洋 239
11.4.1 アジア太平洋：リセッション時のインパクト 239
11.4.2 中国 243
11.4.3 日本 246
- 11.4.3.1 個別化診断製品への関心の高まりが市場を牽引 246
11.4.4 インド 249
- 11.4.4.1 市場成長を後押しする創薬への取り組みの増加 249
11.4.5 オーストラリア 251
- 11.4.5.1 研究機関の多さが市場成長を後押し 251
11.4.6 韓国 254
11.4.7 その他のアジア太平洋 257
11.5 ラテンアメリカ 260
11.5.1 ラテンアメリカ：リセッション時のインパクト 260
11.5.2 ブラジル 264
- 11.5.2.1 バイオ医薬品研究への投資の増加が市場成長を促進 264
11.5.3 メキシコ 266
- 11.5.3.1 市場成長を支えるヘルスケア・エコシステムの拡大 266
11.5.4 その他のラテンアメリカ 269
11.6 中東 272
11.6.1 中東：リセッション時のインパクト 272
11.6.2 GCC地域 276
- 11.6.2.1 サウジアラビア 279
- 11.6.2.2 アラブ首長国連邦 282
- 11.6.2.3 GCC地域 285
11.6.3 その他の中東 288
11.7 アフリカ 291
11.7.1 高まる精密医療への取り組みが市場成長を後押し 291
11.7.2 アフリカ：リセッション時のインパクト 291
12 競合情勢 294
12.1 概要 294
12.2 主要企業の成功戦略 294
12.3 REVENUE SHARE ANALYSIS 295
12.4 市場シェア分析 295
12.5 FINANCIAL METRICS 297
12.6 BRAND/PRODUCT COMPARATIVE ANALYSIS 298
12.6.1 モデル別ブランド/製品比較分析 298
- 12.6.1.1 CHARLES RIVER LABORATORIES 298
- 12.6.1.2 THE JACKSON LABORATORY 299
- 12.6.1.3 INOTIV 299
- 12.6.1.4 TACONIC BIOSCIENCES, INC 299
- 12.6.1.5 BIOCYTOGEN 299
12.6.2 BRAND/PRODUCT COMPARATIVE ANALYSIS、サービス別 300
12.7 企業評価マトリックス：主要企業（<num4>年） 301
12.7.1 STARS 301
12.7.2 EMERGING LEADERS 302
12.7.3 PERVASIVE PLAYERS 302
12.7.4 PARTICIPANTS 302
12.7.5 企業フットプリント（主要プレーヤー） 303
12.7.6 PRODUCT & SERVICE FOOTPRINT 305
12.7.7 地域別フットプリント（主要プレーヤー） 306
12.8 企業評価マトリックス：スタートアップ/中小企業 307
12.8.1 PROGRESSIVE COMPANIES 307
12.8.2 RESPONSIVE COMPANIES 307
12.8.3 DYNAMIC COMPANIES 307
12.8.4 STARTING BLOCKS 307
12.8.5 STARTUPS/SMESの競合ベンチマーキング 309
12.9 競合シナリオ 310
12.9.1 製品展開 310
12.9.2 ディール 311
12.9.3 拡大 312
13 企業プロファイル 313
13.1 主要企業 313
13.1.1 CHARLES RIVER LABORATORIES 313
13.1.2 INOTIV 319
13.1.3 THE JACKSON LABORATORY 326
13.1.4 SHANGHAI MODEL ORGANISMS CENTER, INC 333
13.1.5 JSR CORPORATION 336
13.1.6 BIOCYTOGEN 340
13.1.7 TRANS GENIC INC 344
13.1.8 HARBOUR BIOMED 346
13.1.9 GENOWAY 348
13.1.10 GEMPHARMATECH 352
13.1.11 CYAGEN 355
13.1.12 OZGENE PTY LTD 357
13.1.13 TACONIC BIOSCIENCES, INC 359
13.1.14 TRANSCURE BIOSERVICES 363
13.1.15 MARSHALL BIORESOURCES 364
13.1.16 VIVO BIO TECH LTD 365
13.1.17 INGENIOUS TARGETING LABORATORY 367
13.1.18 JANVIER LABS 369
13.2 他の有力企業 372
13.2.1 APPLIED STEMCELL 372
13.2.2 CREATIVE ANIMODEL 373
13.2.3 JOINN LABORATORIES (CHINA) CO., LTD 374
13.2.4 CREATIVE BIOLABS 375
13.2.5 CRESCENDO BIOLOGICS 376
13.2.6 ARAGEN LIFE SCIENCES 377
13.2.7 POLYGENE 378
14 付録 379
14.1 ディスカッションガイド 379
14.2 ナレッジストア 383
14.3 カスタマイズオプション 385
14.4 関連レポート 385
14.5 執筆者の詳細 386
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
Table of Contents
1 INTRODUCTION 51
1.1 STUDY OBJECTIVES 51
1.2 MARKET DEFINITION 51
1.2.1 INCLUSIONS & EXCLUSIONS 52
1.3 MARKET SCOPE 53
1.3.1 MARKET SEGMENTATION 53
1.3.2 REGIONS COVERED 54
1.4 YEARS CONSIDERED 54
1.5 CURRENCY CONSIDERED 55
1.6 STAKEHOLDERS 55
1.7 LIMITATIONS 55
1.8 SUMMARY OF CHANGES 56
1.9 RECESSION IMPACT 56
2 RESEARCH METHODOLOGY 57
2.1 RESEARCH DATA 57
2.1.1 SECONDARY DATA 58
2.1.2 PRIMARY DATA 58
2.2 MARKET ESTIMATION METHODOLOGY 59
2.2.1 BOTTOM-UP APPROACH 60
2.2.2 INSIGHTS FROM PRIMARY EXPERTS 62
2.3 TOP-DOWN APPROACH 62
2.4 GROWTH FORECAST 64
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION 65
2.6 RESEARCH ASSUMPTIONS 66
2.7 MARKET FORECAST 66
2.8 RISK ANALYSIS 67
2.9 RECESSION IMPACT ANALYSIS 67
3 EXECUTIVE SUMMARY 68
4 PREMIUM INSIGHTS 72
4.1 MICE MODEL MARKET OVERVIEW 72
4.2 ASIA PACIFIC: MICE MODEL MARKET, BY MODEL TYPE & SERVICE (2023) 73
4.3 MICE MODEL MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 74
4.4 MICE MODEL MARKET SHARE, BY END USER 74
5 MARKET OVERVIEW 75
5.1 INTRODUCTION 75
5.2 MARKET DYNAMICS 75
5.2.1 DRIVERS 76
- 5.2.1.1 High adoption of mice models in preclinical studies 76
- 5.2.1.2 Increasing demand for mouse clinical trials (MCTs) 77
- 5.2.1.3 Growing preference for personalized medicine in oncology 78
- 5.2.1.4 Advancements in genetic engineering 78
5.2.2 RESTRAINTS 79
- 5.2.2.1 Introduction of 3D printed models 79
- 5.2.2.2 Ethical concerns and regulatory restrictions 79
5.2.3 OPPORTUNITIES 80
- 5.2.3.1 Utilization of CRISPR in biomedical research 80
- 5.2.3.2 Rising demand for disease-specific models 80
5.2.4 CHALLENGES 80
- 5.2.4.1 Development of alternative animal testing methods 80
- 5.2.4.2 Genetic & Phenotypic variability 81
5.3 MICE MODEL MARKET LANDSCAPE 81
5.3.1 HISTORY OF MICE MODELS 81
5.3.2 MICE MODEL GENERATION PROCESS 81
5.3.3 TECHNIQUES FOR MICE MODEL DEVELOPMENT 82
5.3.4 TECHNOLOGICAL ADVANCEMENTS 83
5.3.5 CONSIDERATIONS FOR MICE MODEL DEVELOPMENT 84
5.4 SUPPLY CHAIN ANALYSIS 84
5.5 VALUE CHAIN ANALYSIS 85
5.6 PRICING ANALYSIS 87
5.6.1 AVERAGE SELLING PRICE TREND ANALYSIS 87
5.7 ECOSYSTEM ANALYSIS 88
5.7.1 MICE MODEL VENDORS 89
5.7.2 MICE MODEL SERVICE VENDORS 89
5.7.3 MICE MODEL END USERS 90
5.7.4 REGULATORY ORGANIZATIONS 91
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 91
5.9 PATENT ANALYSIS 92
5.9.1 METHODOLOGY 92
5.9.2 PATENTS FILED, BY DOCUMENT TYPE, 2014-2024 93
5.9.3 INNOVATION & PATENT APPLICATIONS 93
5.9.4 TOP APPLICANTS 94
5.10 KEY CONFERENCES & EVENTS 96
5.10.1 MICE MODEL MARKET: KEY CONFERENCES & EVENTS (2024-2025) 96
5.11 REGULATORY LANDSCAPE 97
5.11.1 REGULATORY ANALYSIS 97
- 5.11.1.1 North America 97
- 5.11.1.2 Europe 98
- 5.11.1.3 China 99
- 5.11.1.4 Japan 100
- 5.11.1.5 India 100
- 5.11.1.6 Australia 101
- 5.11.1.7 Brazil 101
5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101
5.12 PORTER’S FIVE FORCES ANALYSIS 106
5.12.1 THREAT OF NEW ENTRANTS 106
5.12.2 THREAT OF SUBSTITUTES 107
5.12.3 BARGAINING POWER OF BUYERS 107
5.12.4 BARGAINING POWER OF SUPPLIERS 107
5.12.5 INTENSITY OF COMPETITIVE RIVALRY 107
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 108
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 108
5.13.2 ROLE OF STAKEHOLDERS IN BUYING PROCESS 109
5.13.3 BUYING CRITERIA FOR MICE MODEL MARKET 109
6 MICE MODEL MARKET, BY MODEL TYPE AND SERVICE 111
6.1 INTRODUCTION 112
6.2 MODEL TYPES 112
6.2.1 INBRED MICE 115
- 6.2.1.1 High utilization across research applications to propel market 115
6.2.2 GENETICALLY ENGINEERED MICE 118
- 6.2.2.1 Ability to induce mutations for CVD & cancer research to drive market 118
6.2.3 HYBRID/CONGENIC MICE 121
- 6.2.3.1 Growing focus on biomedical research to boost demand 121
6.2.4 OUTBRED MICE 124
- 6.2.4.1 Genetic diversity benefits to support market growth 124
6.3 SERVICES 127
6.3.1 BREEDING SERVICES 130
- 6.3.1.1 Customization of models for specific research applications to boost demand 130
6.3.2 CRYOPRESERVATION SERVICES 133
- 6.3.2.1 Rising focus on preservation of novel mice models to propel market 133
6.3.3 REDERIVATION SERVICES 136
- 6.3.3.1 Stringent quality assurance standards to fuel market 136
6.3.4 QUARANTINE SERVICES 139
- 6.3.4.1 Rising demand for germ-free mice to support market growth 139
6.3.5 OTHER SERVICES 143
7 MICE MODEL MARKET, BY TECHNOLOGY 147
7.1 INTRODUCTION 148
7.2 CRISPR/CAS9 148
7.2.1 ADVANTAGES SUCH AS SIMPLIFIED DESIGN AND COST EFFICIENCY TO BOOST DEMAND 148
7.3 MICROINJECTION 151
7.3.1 LOW TOXICITY AND HIGH SUCCESS RATE TO PROPEL MARKET 151
7.4 EMBRYONIC STEM CELL INJECTION 154
7.4.1 RISING DEMAND FOR TARGETED MICE MODELS IN IMMUNOLOGICAL RESEARCH TO DRIVE MARKET 154
7.5 NUCLEAR TRANSFER 157
7.5.1 POTENTIAL TO PRODUCE IDENTICAL MICE TO DRIVE MARKET 157
7.6 OTHER TECHNOLOGIES 160
8 MICE MODEL MARKET, BY THERAPEUTIC AREA 164
8.1 INTRODUCTION 165
8.2 ONCOLOGY 165
8.2.1 GROWING FOCUS ON ONCOLOGY THERAPEUTIC DEVELOPMENT TO PROPEL MARKET 165
8.3 METABOLIC DISEASES 169
8.3.1 RISING PREVALENCE OF DIABETES TO DRIVE MARKET 169
8.4 IMMUNOLOGY 172
8.4.1 INCREASING CLINICAL RESEARCH FOR IMMUNOLOGICAL DISORDERS TO FUEL MARKET 172
8.5 NEUROLOGY 175
8.5.1 INCREASING INVESTMENTS IN R&D FOR CNS DISEASES TO SUPPORT MARKET GROWTH 175
8.6 CARDIOVASCULAR DISEASES 178
8.6.1 GROWING FOCUS ON TARGETED TREATMENTS FOR CVD TO BOOST DEMAND 178
8.7 OTHER THERAPEUTIC AREAS 181
9 MICE MODEL MARKET, BY APPLICATION 185
9.1 INTRODUCTION 186
9.2 DRUG DISCOVERY & DEVELOPMENT 186
9.2.1 RISING NUMBER OF CLINICAL TRIALS TO DRIVE MARKET 186
9.3 RESEARCH APPLICATIONS 189
9.3.1 RISING FUNDING FOR CANCER RESEARCH TO BOOST DEMAND 189
9.4 PERSONALIZED MEDICINE 192
9.4.1 GROWING PREFERENCE FOR ONCOLOGY THERAPEUTICS TO PROPEL MARKET 192
10 MICE MODEL MARKET, BY END USER 196
10.1 INTRODUCTION 197
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 197
10.2.1 RISING EXPENDITURE ON R&D FOR DRUG DEVELOPMENT TO BOOST DEMAND 197
10.3 ACADEMIC & RESEARCH INSTITUTES 201
10.3.1 INCREASING FUNDING INITIATIVES FOR LIFE SCIENCES R&D TO SUPPORT MARKET GROWTH 201
10.4 CONTRACT RESEARCH ORGANIZATIONS AND CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS 204
10.4.1 RISING OUTSOURCING OF DRUG DISCOVERY SERVICES TO PROPEL MARKET 204
11 MICE MODEL MARKET, BY REGION 207
11.1 INTRODUCTION 208
11.2 NORTH AMERICA 208
11.2.1 NORTH AMERICA: RECESSION IMPACT 208
11.2.2 US 213
- 11.2.2.1 Rising production of monoclonal antibodies to fuel market for mice models 213
11.2.3 CANADA 216
- 11.2.3.1 Growth in stem cell research activities to support market growth 216
11.3 EUROPE 219
11.3.1 EUROPE: RECESSION IMPACT 219
11.3.2 GERMANY 222
- 11.3.2.1 Growing biotechnology industry to drive market 222
11.3.3 UK 225
- 11.3.3.1 Increasing focus on cancer research to propel market 225
11.3.4 FRANCE 228
- 11.3.4.1 Increased investments in proteomics and genomics to fuel growth 228
11.3.5 ITALY 230
- 11.3.5.1 Growth in pharmaceutical and biotechnology industry to drive market 230
11.3.6 SPAIN 233
- 11.3.6.1 Extensive R&D pipeline to support market growth 233
11.3.7 REST OF EUROPE 236
11.4 ASIA PACIFIC 239
11.4.1 ASIA PACIFIC: RECESSION IMPACT 239
11.4.2 CHINA 243
- 11.4.2.1 Growing funding and investments in life sciences research to drive market 243
11.4.3 JAPAN 246
- 11.4.3.1 Increasing focus on personalized diagnostics products to drive market 246
11.4.4 INDIA 249
- 11.4.4.1 Increasing initiatives for drug discovery to boost market growth 249
11.4.5 AUSTRALIA 251
- 11.4.5.1 High number of research institutes to favor market growth 251
11.4.6 SOUTH KOREA 254
- 11.4.6.1 Rising R&D investments in drug development to fuel uptake of genetically engineered mice models 254
11.4.7 REST OF ASIA PACIFIC 257
11.5 LATIN AMERICA 260
11.5.1 LATIN AMERICA: RECESSION IMPACT 260
11.5.2 BRAZIL 264
- 11.5.2.1 Increasing Investments in Biopharmaceutical research to propel market growth 264
11.5.3 MEXICO 266
- 11.5.3.1 Expanding healthcare ecosystem to support market growth 266
11.5.4 REST OF LATIN AMERICA 269
11.6 MIDDLE EAST 272
11.6.1 MIDDLE EAST: RECESSION IMPACT 272
11.6.2 GCC COUNTRIES 276
- 11.6.2.1 SAUDI ARABIA 279
- 11.6.2.1.1 Growing focus on advancement of healthcare sector to boost market growth 279
- 11.6.2.2 UNITED ARAB EMIRATES 282
- 11.6.2.2.1 Increasing R&D activities and growing demand for personalized medicine to propel market 282
- 11.6.2.3 REST OF GCC COUNTRIES 285
- 11.6.2.1 SAUDI ARABIA 279
11.6.3 REST OF MIDDLE EAST 288
11.7 AFRICA 291
11.7.1 GROWING PRECISION MEDICINE INITIATIVES TO FUEL MARKET GROWTH 291
11.7.2 AFRICA: RECESSION IMPACT 291
12 COMPETITIVE LANDSCAPE 294
12.1 OVERVIEW 294
12.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN 294
12.3 REVENUE SHARE ANALYSIS 295
12.4 MARKET SHARE ANALYSIS 295
12.5 FINANCIAL METRICS 297
12.6 BRAND/PRODUCT COMPARATIVE ANALYSIS 298
12.6.1 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY MODEL 298
- 12.6.1.1 CHARLES RIVER LABORATORIES 298
- 12.6.1.2 THE JACKSON LABORATORY 299
- 12.6.1.3 INOTIV 299
- 12.6.1.4 TACONIC BIOSCIENCES, INC 299
- 12.6.1.5 BIOCYTOGEN 299
12.6.2 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY SERVICE 300
- 12.6.2.1 CHARLES RIVER LABORATORIES 300
- 12.6.2.2 THE JACKSON LABORATORY 300
- 12.6.2.3 INOTIV 301
- 12.6.2.4 TACONIC BIOSCIENCES, INC 301
- 12.6.2.5 BIOCYTOGEN 301
12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS (2023) 301
12.7.1 STARS 301
12.7.2 EMERGING LEADERS 302
12.7.3 PERVASIVE PLAYERS 302
12.7.4 PARTICIPANTS 302
12.7.5 COMPANY FOOTPRINT (KEY PLAYERS) 303
12.7.6 PRODUCT & SERVICE FOOTPRINT 305
12.7.7 REGIONAL FOOTPRINT (KEY PLAYERS) 306
12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES 307
12.8.1 PROGRESSIVE COMPANIES 307
12.8.2 RESPONSIVE COMPANIES 307
12.8.3 DYNAMIC COMPANIES 307
12.8.4 STARTING BLOCKS 307
12.8.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES 309
12.9 COMPETITIVE SCENARIO 310
12.9.1 PRODUCT LAUNCHES 310
12.9.2 DEALS 311
12.9.3 EXPANSIONS 312
13 COMPANY PROFILES 313
13.1 KEY PLAYERS 313
13.1.1 CHARLES RIVER LABORATORIES 313
13.1.2 INOTIV 319
13.1.3 THE JACKSON LABORATORY 326
13.1.4 SHANGHAI MODEL ORGANISMS CENTER, INC 333
13.1.5 JSR CORPORATION 336
13.1.6 BIOCYTOGEN 340
13.1.7 TRANS GENIC INC 344
13.1.8 HARBOUR BIOMED 346
13.1.9 GENOWAY 348
13.1.10 GEMPHARMATECH 352
13.1.11 CYAGEN 355
13.1.12 OZGENE PTY LTD 357
13.1.13 TACONIC BIOSCIENCES, INC 359
13.1.14 TRANSCURE BIOSERVICES 363
13.1.15 MARSHALL BIORESOURCES 364
13.1.16 VIVO BIO TECH LTD 365
13.1.17 INGENIOUS TARGETING LABORATORY 367
13.1.18 JANVIER LABS 369
13.2 OTHER PLAYERS 372
13.2.1 APPLIED STEMCELL 372
13.2.2 CREATIVE ANIMODEL 373
13.2.3 JOINN LABORATORIES (CHINA) CO., LTD 374
13.2.4 CREATIVE BIOLABS 375
13.2.5 CRESCENDO BIOLOGICS 376
13.2.6 ARAGEN LIFE SCIENCES 377
13.2.7 POLYGENE 378
14 APPENDIX 379
14.1 DISCUSSION GUIDE 379
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 383
14.3 CUSTOMIZATION OPTIONS 385
14.4 RELATED REPORTS 385
14.5 AUTHOR DETAILS 386
TABLE 1 FACTOR ANALYSIS TABLE 2 MICE MODEL MARKET: IMPACT ANALYSIS TABLE 3 AVERAGE SELLING PRICE TREND OF MODEL TYPE, BY KEY PLAYER TABLE 4 MICE MODEL MARKET: ROLE IN ECOSYSTEM, BY MICE MODEL VENDORS TABLE 5 MICE MODEL MARKET: ROLE IN ECOSYSTEM, BY SERVICE VENDOR TABLE 6 MICE MODEL MARKET: ROLE IN ECOSYSTEM, BY END USER TABLE 7 MICE MODEL MARKET: ROLE IN ECOSYSTEM, BY REGULATORY ORGANIZATION TABLE 8 PATENTS FILED (2014-2024) TABLE 9 TOP 20 PATENT OWNERS IN MICE MODEL MARKET (2014-2024) TABLE 10 PATENTS IN MICE MODEL MARKET (2024) TABLE 11 MICE MODEL MARKET: CONFERENCES & EVENTS (2024-2025) TABLE 12 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS TABLE 13 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS TABLE 14 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS TABLE 15 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS TABLE 16 MICE MODEL MARKET: REGULATORY SCENARIO TABLE 17 MICE MODEL MARKET: PORTER’S FIVE FORCES ANALYSIS TABLE 18 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR MICE MODELS & SERVICES TABLE 19 BUYING CRITERIA FOR MICE MODEL TYPE & SERVICE, BY END USER TABLE 20 MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2022-2029 (USD MILLION) TABLE 21 MICE MODEL MARKET, BY REGION, 2022-2029 (USD MILLION) TABLE 22 NORTH AMERICA: MICE MODEL TYPE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 23 EUROPE: MICE MODEL TYPE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 24 ASIA PACIFIC: MICE MODEL TYPE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 25 LATIN AMERICA: MICE MODEL TYPE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 26 MIDDLE EAST: MICE MODEL TYPE MARKET, BY REGION, 2022-2029 (USD MILLION) TABLE 27 GCC COUNTRIES: MICE MODEL TYPE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 28 MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION) TABLE 29 INBRED MICE MODEL MARKET, BY REGION, 2022-2029 (USD MILLION) TABLE 30 NORTH AMERICA: INBRED MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 31 EUROPE: INBRED MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 32 ASIA PACIFIC: INBRED MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 33 LATIN AMERICA: INBRED MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 34 MIDDLE EAST: INBRED MICE MODEL MARKET, BY REGION, 2022-2029 (USD MILLION) TABLE 35 GCC COUNTRIES: INBRED MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 36 GENETICALLY ENGINEERED MICE MODEL MARKET, BY REGION, 2022-2029 (USD MILLION) TABLE 37 NORTH AMERICA: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 38 EUROPE: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 39 ASIA PACIFIC: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 40 LATIN AMERICA: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 41 MIDDLE EAST: GENETICALLY ENGINEERED MICE MODEL MARKET, BY REGION, 2022-2029 (USD MILLION) TABLE 42 GCC COUNTRIES: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 43 HYBRID/CONGENIC MICE MODEL MARKET, BY REGION, 2022-2029 (USD MILLION) TABLE 44 NORTH AMERICA: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 45 EUROPE: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 46 ASIA PACIFIC: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 47 LATIN AMERICA: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 48 MIDDLE EAST: HYBRID/CONGENIC MICE MODEL MARKET, BY REGION, 2022-2029 (USD MILLION) TABLE 49 GCC COUNTRIES: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 50 OUTBRED MICE MODEL MARKET, BY REGION, 2022-2029 (USD MILLION) TABLE 51 NORTH AMERICA: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 52 EUROPE: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 53 ASIA PACIFIC: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 54 LATIN AMERICA: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 55 MIDDLE EAST: OUTBRED MICE MODEL MARKET, BY REGION, 2022-2029 (USD MILLION) TABLE 56 GCC COUNTRIES: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 57 MICE MODEL SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) TABLE 58 NORTH AMERICA: MICE MODEL SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 59 EUROPE: MICE MODEL SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 60 ASIA PACIFIC: MICE MODEL SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 61 LATIN AMERICA: MICE MODEL SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 62 MIDDLE EAST: MICE MODEL SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) TABLE 63 GCC COUNTRIES: MICE MODEL SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 64 MICE MODEL SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) TABLE 65 MICE MODEL BREEDING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) TABLE 66 NORTH AMERICA: MICE MODEL BREEDING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 67 EUROPE: MICE MODEL BREEDING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 68 ASIA PACIFIC: MICE MODEL BREEDING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 69 LATIN AMERICA: MICE MODEL BREEDING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 70 MIDDLE EAST: MICE MODEL BREEDING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) TABLE 71 GCC COUNTRIES: MICE MODEL BREEDING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) TABLE 72 MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) TABLE 73 NORTH AMERICA: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 74 EUROPE: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 75 ASIA PACIFIC: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 76 LATIN AMERICA: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 77 MIDDLE EAST: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY REGION 2022-2029 (USD MILLION) TABLE 78 GCC COUNTRIES: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 79 MICE MODEL REDERIVATION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) TABLE 80 NORTH AMERICA: MICE MODEL REDERIVATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 81 EUROPE: MICE MODEL REDERIVATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 82 ASIA PACIFIC: MICE MODEL REDERIVATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 83 LATIN AMERICA: MICE MODEL REDERIVATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 84 MIDDLE EAST: MICE MODEL REDERIVATION SERVICES, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 85 GCC COUNTRIES: MICE MODEL REDERIVATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 86 MICE MODEL QUARANTINE SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) TABLE 87 NORTH AMERICA: MICE MODEL QUARANTINE SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 88 EUROPE: MICE MODEL QUARANTINE SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 89 ASIA PACIFIC: MICE MODEL QUARANTINE SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 90 LATIN AMERICA: MICE MODEL QUARANTINE SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 91 MIDDLE EAST: MICE MODEL QUARANTINE SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) TABLE 92 GCC COUNTRIES: MICE MODEL QUARANTINE SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 93 MICE MODEL OTHER SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) TABLE 94 NORTH AMERICA: MICE MODEL OTHER SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 95 EUROPE: MICE MODEL OTHER SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 96 ASIA PACIFIC: MICE MODEL OTHER SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 97 LATIN AMERICA: MICE MODEL OTHER SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 98 MIDDLE EAST: MICE MODEL OTHER SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) TABLE 99 GCC COUNTRIES: MICE MODEL OTHER SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 100 MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) TABLE 101 CRISPR/CAS9 MARKET, BY REGION, 2022-2029 (USD MILLION) TABLE 102 NORTH AMERICA: CRISPR/CAS9 MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 103 EUROPE: CRISPR/CAS9 MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 104 ASIA PACIFIC: CRISPR/CAS9 MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 105 LATIN AMERICA: CRISPR/CAS9 MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 106 MIDDLE EAST: CRISPR/CAS9 MARKET, BY REGION, 2022-2029 (USD MILLION) TABLE 107 GCC COUNTRIES: CRISPR/CAS9 MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 108 MICROINJECTION MARKET, BY REGION, 2022-2029 (USD MILLION) TABLE 109 NORTH AMERICA: MICROINJECTION MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 110 EUROPE: MICROINJECTION MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 111 ASIA PACIFIC: MICROINJECTION MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 112 LATIN AMERICA: MICROINJECTION MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 113 MIDDLE EAST: MICROINJECTION MARKET, BY REGION, 2022-2029 (USD MILLION) TABLE 114 GCC COUNTRIES: MICROINJECTION MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 115 EMBRYONIC STEM CELL INJECTION MARKET, BY REGION, 2022-2029 (USD MILLION) TABLE 116 NORTH AMERICA: EMBRYONIC STEM CELL INJECTION MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 117 EUROPE: EMBRYONIC STEM CELL INJECTION MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 118 ASIA PACIFIC: EMBRYONIC STEM CELL INJECTION MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 119 LATIN AMERICA: EMBRYONIC STEM CELL INJECTION MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 120 MIDDLE EAST: EMBRYONIC STEM CELL INJECTION MARKET, BY REGION, 2022-2029 (USD MILLION) TABLE 121 GCC COUNTRIES: EMBRYONIC STEM CELL INJECTION MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 122 NUCLEAR TRANSFER MARKET, BY REGION, 2022-2029 (USD MILLION) TABLE 123 NORTH AMERICA: NUCLEAR TRANSFER MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 124 EUROPE: NUCLEAR TRANSFER MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 125 ASIA PACIFIC: NUCLEAR TRANSFER MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 126 LATIN AMERICA: NUCLEAR TRANSFER MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 127 MIDDLE EAST: NUCLEAR TRANSFER MARKET, BY REGION, 2022-2029 (USD MILLION) TABLE 128 GCC COUNTRIES: NUCLEAR TRANSFER MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 129 OTHER TECHNOLOGIES MARKET, BY REGION, 2022-2029 (USD MILLION) TABLE 130 NORTH AMERICA: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 131 EUROPE: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 132 ASIA PACIFIC: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 133 LATIN AMERICA: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 134 MIDDLE EAST: OTHER TECHNOLOGIES MARKET, BY REGION, 2022-2029 (USD MILLION) TABLE 135 GCC COUNTRIES: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 136 MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION) TABLE 137 MICE MODEL MARKET FOR ONCOLOGY, BY REGION, 2022-2029 (USD MILLION) TABLE 138 NORTH AMERICA: MICE MODEL MARKET FOR ONCOLOGY, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 139 EUROPE: MICE MODEL MARKET FOR ONCOLOGY, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 140 ASIA PACIFIC: MICE MODEL MARKET FOR ONCOLOGY, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 141 LATIN AMERICA: MICE MODEL MARKET FOR ONCOLOGY, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 142 MIDDLE EAST: MICE MODEL MARKET FOR ONCOLOGY, BY REGION, 2022-2029 (USD MILLION) TABLE 143 GCC COUNTRIES: MICE MODEL MARKET FOR ONCOLOGY, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 144 MICE MODEL MARKET FOR METABOLIC DISEASES, BY REGION, 2022-2029 (USD MILLION) TABLE 145 NORTH AMERICA: MICE MODEL MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 146 EUROPE: MICE MODEL MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 147 ASIA PACIFIC: MICE MODEL MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 148 LATIN AMERICA: MICE MODEL MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 149 MIDDLE EAST: MICE MODEL MARKET FOR METABOLIC DISEASES, BY REGION, 2022-2029 (USD MILLION) TABLE 150 GCC COUNTRIES: MICE MODEL MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 151 MICE MODEL MARKET FOR IMMUNOLOGY, BY REGION, 2022-2029 (USD MILLION) TABLE 152 NORTH AMERICA: MICE MODEL MARKET FOR IMMUNOLOGY, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 153 EUROPE: MICE MODEL MARKET FOR IMMUNOLOGY, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 154 ASIA PACIFIC: MICE MODEL MARKET FOR IMMUNOLOGY, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 155 LATIN AMERICA: MICE MODEL MARKET FOR IMMUNOLOGY, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 156 MIDDLE EAST: MICE MODEL MARKET FOR IMMUNOLOGY, BY REGION, 2022-2029 (USD MILLION) TABLE 157 GCC COUNTRIES: MICE MODEL MARKET FOR IMMUNOLOGY, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 158 MICE MODEL MARKET FOR NEUROLOGY, BY REGION, 2022-2029 (USD MILLION) TABLE 159 NORTH AMERICA: MICE MODEL MARKET FOR NEUROLOGY, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 160 EUROPE: MICE MODEL MARKET FOR NEUROLOGY, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 161 ASIA PACIFIC: MICE MODEL MARKET FOR NEUROLOGY, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 162 LATIN AMERICA: MICE MODEL MARKET FOR NEUROLOGY, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 163 MIDDLE EAST: MICE MODEL MARKET FOR NEUROLOGY, BY REGION, 2022-2029 (USD MILLION) TABLE 164 GCC COUNTRIES: MICE MODEL MARKET FOR NEUROLOGY, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 165 MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2022-2029 (USD MILLION) TABLE 166 NORTH AMERICA: MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 167 EUROPE: MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 168 ASIA PACIFIC: MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 169 LATIN AMERICA: MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 170 MIDDLE EAST: MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2022-2029 (USD MILLION) TABLE 171 GCC COUNTRIES: MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 172 MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2022-2029 (USD MILLION) TABLE 173 NORTH AMERICA: MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 174 EUROPE: MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 175 ASIA PACIFIC: MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 176 LATIN AMERICA: MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 177 MIDDLE EAST: MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2022-2029 (USD MILLION) TABLE 178 GCC COUNTRIES: MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 179 MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION) TABLE 180 MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2022-2029 (USD MILLION) TABLE 181 NORTH AMERICA: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 182 EUROPE: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 183 ASIA PACIFIC: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 184 LATIN AMERICA: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 185 MIDDLE EAST: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 186 GCC COUNTRIES: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 187 MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022-2029 (USD MILLION) TABLE 188 NORTH AMERICA: MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 189 EUROPE: MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 190 ASIA PACIFIC: MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 191 LATIN AMERICA: MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 192 MIDDLE EAST: MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 193 GCC COUNTRIES: MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 194 MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2022-2029 (USD MILLION) TABLE 195 NORTH AMERICA: MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 196 EUROPE: MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 197 ASIA PACIFIC: MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 198 LATIN AMERICA: MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 199 MIDDLE EAST: MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 200 GCC COUNTRIES: MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 201 MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION) TABLE 202 MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION) TABLE 203 NORTH AMERICA: MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 204 EUROPE: MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 205 ASIA PACIFIC: MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 206 LATIN AMERICA: MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 207 MIDDLE EAST: MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION) TABLE 208 GCC COUNTRIES: MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 209 MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION) TABLE 210 NORTH AMERICA: MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 211 EUROPE: MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 212 ASIA PACIFIC: MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 213 LATIN AMERICA: MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 214 MIDDLE EAST: MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION) TABLE 215 GCC COUNTRIES: MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 216 MICE MODEL MARKET FOR CROS & CDMOS, BY REGION, 2022-2029 (USD MILLION) TABLE 217 NORTH AMERICA: MICE MODEL MARKET FOR CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 218 EUROPE: MICE MODEL MARKET FOR CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 219 ASIA PACIFIC: MICE MODEL MARKET FOR CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 220 LATIN AMERICA: MICE MODEL MARKET FOR CROS & CDMOS, BY COUNTRY, 2022-2029 USD MILLION) TABLE 221 MIDDLE EAST: MICE MODEL MARKET FOR CROS & CDMOS, BY REGION, 2022-2029 (USD MILLION) TABLE 222 GCC COUNTRIES: MICE MODEL MARKET FOR CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 223 MICE MODEL MARKET, BY REGION, 2022-2029 (USD MILLION) TABLE 224 NORTH AMERICA: MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 225 NORTH AMERICA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION) TABLE 226 NORTH AMERICA: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION) TABLE 227 NORTH AMERICA: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION) TABLE 228 NORTH AMERICA: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) TABLE 229 NORTH AMERICA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION) TABLE 230 NORTH AMERICA: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION) TABLE 231 NORTH AMERICA: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION TABLE 232 US: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION) TABLE 233 US: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION) TABLE 234 US: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION) TABLE 235 US: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) TABLE 236 US: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION) TABLE 237 US: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION) TABLE 238 US: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION TABLE 239 CANADA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION) TABLE 240 CANADA: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION) TABLE 241 CANADA: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION) TABLE 242 CANADA: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) TABLE 243 CANADA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION) TABLE 244 CANADA: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION) TABLE 245 CANADA: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION TABLE 246 EUROPE: MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 247 EUROPE: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION) TABLE 248 EUROPE: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION) TABLE 249 EUROPE: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION) TABLE 250 EUROPE: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) TABLE 251 EUROPE: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION) TABLE 252 EUROPE: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION) TABLE 253 EUROPE: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION) TABLE 254 GERMANY: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION) TABLE 255 GERMANY: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION) TABLE 256 GERMANY: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION) TABLE 257 GERMANY: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) TABLE 258 GERMANY: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION) TABLE 259 GERMANY: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION) TABLE 260 GERMANY: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION) TABLE 261 UK: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION) TABLE 262 UK: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION) TABLE 263 UK: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION) TABLE 264 UK: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) TABLE 265 UK: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION) TABLE 266 UK: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION) TABLE 267 UK: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION) TABLE 268 FRANCE: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION) TABLE 269 FRANCE: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION) TABLE 270 FRANCE: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION) TABLE 271 FRANCE: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) TABLE 272 FRANCE: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION) TABLE 273 FRANCE: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION) TABLE 274 FRANCE: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION) TABLE 275 ITALY: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION) TABLE 276 ITALY: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION) TABLE 277 ITALY: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION) TABLE 278 ITALY: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) TABLE 279 ITALY: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION) TABLE 280 ITALY: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION) TABLE 281 ITALY: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION) TABLE 282 SPAIN: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION) TABLE 283 SPAIN: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION) TABLE 284 SPAIN: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION) TABLE 285 SPAIN: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) TABLE 286 SPAIN: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION) TABLE 287 SPAIN: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION) TABLE 288 SPAIN: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION) TABLE 289 REST OF EUROPE: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION) TABLE 290 REST OF EUROPE: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION) TABLE 291 REST OF EUROPE: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION) TABLE 292 REST OF EUROPE: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) TABLE 293 REST OF EUROPE: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION) TABLE 294 REST OF EUROPE: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION) TABLE 295 REST OF EUROPE: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION) TABLE 296 ASIA PACIFIC: MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 297 ASIA PACIFIC: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION) TABLE 298 ASIA PACIFIC: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION) TABLE 299 ASIA PACIFIC: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION) TABLE 300 ASIA PACIFIC: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) TABLE 301 ASIA PACIFIC: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION) TABLE 302 ASIA PACIFIC: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION) TABLE 303 ASIA PACIFIC: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION) TABLE 304 CHINA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION) TABLE 305 CHINA: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION) TABLE 306 CHINA: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION) TABLE 307 CHINA: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) TABLE 308 CHINA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION) TABLE 309 CHINA: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION) TABLE 310 CHINA: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION) TABLE 311 JAPAN: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION) TABLE 312 JAPAN: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION) TABLE 313 JAPAN: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION) TABLE 314 JAPAN: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) TABLE 315 JAPAN: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION) TABLE 316 JAPAN: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION) TABLE 317 JAPAN: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION) TABLE 318 INDIA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION) TABLE 319 INDIA: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION) TABLE 320 INDIA: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION) TABLE 321 INDIA: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) TABLE 322 INDIA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION) TABLE 323 INDIA: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION) TABLE 324 INDIA: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION) TABLE 325 AUSTRALIA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION) TABLE 326 AUSTRALIA: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION) TABLE 327 AUSTRALIA: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION) TABLE 328 AUSTRALIA: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) TABLE 329 AUSTRALIA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION) TABLE 330 AUSTRALIA: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION) TABLE 331 AUSTRALIA: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION) TABLE 332 SOUTH KOREA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION) TABLE 333 SOUTH KOREA: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION) TABLE 334 SOUTH KOREA: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION) TABLE 335 SOUTH KOREA: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) TABLE 336 SOUTH KOREA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION) TABLE 337 SOUTH KOREA: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION) TABLE 338 SOUTH KOREA: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION) TABLE 339 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION) TABLE 340 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION) TABLE 341 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION) TABLE 342 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) TABLE 343 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION) TABLE 344 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION) TABLE 345 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION) TABLE 346 LATIN AMERICA: MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 347 LATIN AMERICA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION) TABLE 348 LATIN AMERICA: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION) TABLE 349 LATIN AMERICA: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION) TABLE 350 LATIN AMERICA: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) TABLE 351 LATIN AMERICA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION) TABLE 352 LATIN AMERICA: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION) TABLE 353 LATIN AMERICA: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION TABLE 354 BRAZIL: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION) TABLE 355 BRAZIL: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION) TABLE 356 BRAZIL: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION) TABLE 357 BRAZIL: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) TABLE 358 BRAZIL: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION) TABLE 359 BRAZIL: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION) TABLE 360 BRAZIL: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION TABLE 361 MEXICO: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION) TABLE 362 MEXICO: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION) TABLE 363 MEXICO: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION) TABLE 364 MEXICO: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) TABLE 365 MEXICO: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION) TABLE 366 MEXICO: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION) TABLE 367 MEXICO: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION TABLE 368 REST OF LATIN AMERICA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION) TABLE 369 REST OF LATIN AMERICA: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION) TABLE 370 REST OF LATIN AMERICA: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION) TABLE 371 REST OF LATIN AMERICA: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) TABLE 372 REST OF LATIN AMERICA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION) TABLE 373 REST OF LATIN AMERICA: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION) TABLE 374 REST OF LATIN AMERICA: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION TABLE 375 MIDDLE EAST: MICE MODEL MARKET, BY REGION, 2022-2029 (USD MILLION) TABLE 376 MIDDLE EAST: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION) TABLE 377 MIDDLE EAST: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION) TABLE 378 MIDDLE EAST: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION) TABLE 379 MIDDLE EAST: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) TABLE 380 MIDDLE EAST: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION) TABLE 381 MIDDLE EAST: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION) TABLE 382 MIDDLE EAST: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION TABLE 383 GCC COUNTRIES: MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION) TABLE 384 GCC COUNTRIES: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION) TABLE 385 GCC COUNTRIES: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION) TABLE 386 GCC COUNTRIES: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION) TABLE 387 GCC COUNTRIES: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) TABLE 388 GCC COUNTRIES: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION) TABLE 389 GCC COUNTRIES: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION) TABLE 390 GCC COUNTRIES: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION TABLE 391 SAUDI ARABIA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION) TABLE 392 SAUDI ARABIA: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION) TABLE 393 SAUDI ARABIA: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION) TABLE 394 SAUDI ARABIA: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) TABLE 395 SAUDI ARABIA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION) TABLE 396 SAUDI ARABIA: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION) TABLE 397 SAUDI ARABIA: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION) TABLE 398 UNITED ARAB EMIRATES: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION) TABLE 399 UNITED ARAB EMIRATES: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION) TABLE 400 UNITED ARAB EMIRATES: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION) TABLE 401 UNITED ARAB EMIRATES: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) TABLE 402 UNITED ARAB EMIRATES: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION) TABLE 403 UNITED ARAB EMIRATES: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION) TABLE 404 UNITED ARAB EMIRATES: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION TABLE 405 REST OF GCC COUNTRIES: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION) TABLE 406 REST OF GCC COUNTRIES: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION) TABLE 407 REST OF GCC COUNTRIES: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION) TABLE 408 REST OF GCC COUNTRIES: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) TABLE 409 REST OF GCC COUNTRIES: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION) TABLE 410 REST OF GCC COUNTRIES: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION) TABLE 411 REST OF GCC COUNTRIES: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION TABLE 412 REST OF MIDDLE EAST: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION) TABLE 413 REST OF MIDDLE EAST: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION) TABLE 414 REST OF MIDDLE EAST: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION) TABLE 415 REST OF MIDDLE EAST: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) TABLE 416 REST OF MIDDLE EAST: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION) TABLE 417 REST OF MIDDLE EAST: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION) TABLE 418 REST OF MIDDLE EAST: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION TABLE 419 AFRICA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION) TABLE 420 AFRICA: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION) TABLE 421 AFRICA: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION) TABLE 422 AFRICA: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) TABLE 423 AFRICA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION) TABLE 424 AFRICA: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION) TABLE 425 AFRICA: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION TABLE 426 KEY PLAYERS STRATEGIES IN MICE MODEL MARKET, 2021-2024 TABLE 427 MICE MODEL MARKET: INTENSITY OF COMPETITIVE RIVALRY TABLE 428 INDUSTRY FOOTPRINT (KEY PLAYERS) TABLE 429 MICE MODEL MARKET: PRODUCT & SERVICE FOOTPRINT (KEY PLAYERS) TABLE 430 REGIONAL FOOTPRINT (KEY PLAYERS) TABLE 431 MICE MODEL MARKET: KEY STARTUPS/SMES TABLE 432 MICE MODEL MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES TABLE 433 MICE MODEL MARKET: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2024 TABLE 434 MICE MODEL MARKET: DEALS, JANUARY 2021-JANUARY 2024 TABLE 435 MICE MODEL MARKET: EXPANSIONS, JANUARY 2021-JANUARY 2024 TABLE 436 CHARLES RIVER LABORATORIES: BUSINESS OVERVIEW TABLE 437 CHARLES RIVER LABORATORIES: PRODUCTS/SERVICES OFFERED TABLE 438 CHARLES RIVER LABORATORIES: DEALS TABLE 439 CHARLES RIVER LABORATORIES: EXPANSIONS TABLE 440 INOTIV: BUSINESS OVERVIEW TABLE 441 INOTIV: PRODUCTS/SERVICES OFFERED TABLE 442 INOTIV: PRODUCT LAUNCHES TABLE 443 INOTIV: DEALS TABLE 444 INOTIV: EXPANSIONS TABLE 445 THE JACKSON LABORATORY: BUSINESS OVERVIEW TABLE 446 THE JACKSON LABORATORY: PRODUCTS/SERVICES OFFERED TABLE 447 THE JACKSON LABORATORY: PRODUCT LAUNCHES TABLE 448 THE JACKSON LABORATORY: DEALS TABLE 449 SHANGHAI MODEL ORGANISMS CENTER, INC.: BUSINESS OVERVIEW TABLE 450 SHANGHAI MODEL ORGANISMS CENTER, INC.: PRODUCTS/SERVICES OFFERED TABLE 451 JSR CORPORATION: BUSINESS OVERVIEW TABLE 452 JSR CORPORATION: PRODUCTS/SERVICES OFFERED TABLE 453 JSR CORPORATION: DEALS TABLE 454 BIOCYTOGEN: BUSINESS OVERVIEW TABLE 455 BIOCYTOGEN: PRODUCTS/SERVICES OFFERED TABLE 456 BIOCYTOGEN: PRODUCT LAUNCHES TABLE 457 BIOCYTOGEN: DEALS TABLE 458 BIOCYTOGEN: EXPANSIONS TABLE 459 TRANS GENIC INC.: BUSINESS OVERVIEW TABLE 460 TRANS GENIC, INC.: PRODUCTS/SERVICES OFFERED TABLE 461 HARBOUR BIOMED: BUSINESS OVERVIEW TABLE 462 HARBOUR BIOMED: PRODUCTS/SERVICES OFFERED TABLE 463 HARBOUR BIOMED: OTHER DEVELOPMENTS TABLE 464 GENOWAY: BUSINESS OVERVIEW TABLE 465 GENOWAY: PRODUCTS/SERVICES OFFERED TABLE 466 GENOWAY: DEALS TABLE 467 GEMPHARMATECH: BUSINESS OVERVIEW TABLE 468 GEMPHARMATECH: PRODUCTS/SERVICES OFFERED TABLE 469 GEMPHARMATECH: DEALS TABLE 470 GEMPHARMATECH: EXPANSIONS TABLE 471 CYAGEN: BUSINESS OVERVIEW TABLE 472 CYAGEN: PRODUCTS/SERVICES OFFERED TABLE 473 OZGENE PTY LTD.: BUSINESS OVERVIEW TABLE 474 OZGENE PTY LTD.: PRODUCTS/SERVICES OFFERED TABLE 475 DEALS TABLE 476 TACONIC BIOSCIENCES, INC.: BUSINESS OVERVIEW TABLE 477 TACONIC BIOSCIENCES, INC.: PRODUCTS/SERVICES OFFERED TABLE 478 TACONIC BIOSCIENCES, INC.: PRODUCT LAUNCHES TABLE 479 TACONIC BIOSCIENCES, INC.: DEALS TABLE 480 TRANSCURE BIOSERVICES: BUSINESS OVERVIEW TABLE 481 TRANSCURE BIOSERVICES: PRODUCTS/SERVICES OFFERED TABLE 482 MARSHALL BIORESOURCES: BUSINESS OVERVIEW TABLE 483 MARSHALL BIORESOURCES: PRODUCTS/SERVICES OFFERED TABLE 484 VIVO BIO TECH LTD.: BUSINESS OVERVIEW TABLE 485 VIVO BIO TECH LTD.: PRODUCTS/SERVICES OFFERED TABLE 486 INGENIOUS TARGETING LABORATORY: BUSINESS OVERVIEW TABLE 487 INGENIOUS TARGETING LABORATORY: PRODUCTS/SERVICES OFFERED TABLE 488 JANVIER LABS: BUSINESS OVERVIEW TABLE 489 JANVIER LABS: PRODUCTS/SERVICES OFFERED TABLE 490 APPLIED STEMCELL: BUSINESS OVERVIEW TABLE 491 CREATIVE ANIMODEL: BUSINESS OVERVIEW TABLE 492 JOINN LABORATORIES (CHINA) CO., LTD.: BUSINESS OVERVIEW TABLE 493 CREATIVE BIOLABS: BUSINESS OVERVIEW TABLE 494 CRESCENDO BIOLOGICS: BUSINESS OVERVIEW TABLE 495 ARAGEN LIFE SCIENCES: BUSINESS OVERVIEW TABLE 496 POLYGENE: BUSINESS OVERVIEW
FIGURE 1 RESEARCH DESIGN FIGURE 2 MICE MODEL MARKET: BREAKDOWN OF PRIMARIES FIGURE 3 MICE MODEL MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023 FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023 FIGURE 5 ILLUSTRATIVE EXAMPLE OF CHARLES RIVER LABORATORIES: REVENUE SHARE ANALYSIS (2023) FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH FIGURE 8 MICE MODEL MARKET: CAGR PROJECTIONS FIGURE 9 DATA TRIANGULATION METHODOLOGY FIGURE 10 MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2024 VS. 2029 (USD MILLION) FIGURE 11 MICE MODEL MARKET, BY TECHNOLOGY, 2024 VS. 2029 (USD MILLION) FIGURE 12 MICE MODEL MARKET, BY THERAPEUTIC AREA, 2024 VS. 2029 (USD MILLION) FIGURE 13 MICE MODEL MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) FIGURE 14 GEOGRAPHICAL SNAPSHOT OF MICE MODEL MARKET FIGURE 15 RISING INVESTMENTS AND ADVANCEMENTS IN MOUSE MODEL TECHNOLOGY TO DRIVE MARKET GROWTH FIGURE 16 MODEL TYPE SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD FIGURE 19 MICE MODEL MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FIGURE 20 MICE MODEL MARKET: SUPPLY CHAIN ANALYSIS FIGURE 21 MICE MODEL MARKET: VALUE CHAIN ANALYSIS FIGURE 22 MICE MODEL MARKET: ECOSYSTEM ANALYSIS FIGURE 23 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES FIGURE 24 TOTAL NUMBER OF PATENTS GRANTED (2014-2024) FIGURE 25 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS (2014-2024) FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MICE MODEL MARKET FIGURE 27 KEY BUYING CRITERIA FOR END USERS FIGURE 28 NORTH AMERICA: MICE MODEL MARKET SNAPSHOT FIGURE 29 ASIA PACIFIC: MICE MODEL MARKET SNAPSHOT FIGURE 30 REVENUE SHARE ANALYSIS FOR KEY COMPANIES, 2019-2023 (USD MILLION) FIGURE 31 MICE MODEL MARKET SHARE ANALYSIS OF KEY PLAYERS (2023) FIGURE 32 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY MODEL FIGURE 33 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY SERVICE FIGURE 34 MICE MODEL MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS) 2023 FIGURE 35 MICE MODEL MARKET: COMPANY FOOTPRINT KEY PLAYERS FIGURE 36 MICE MODEL MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 FIGURE 37 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2022) FIGURE 40 SHANGHAI MODEL ORGANISMS CENTER, INC.: COMPANY SNAPSHOT (2022) FIGURE 41 JSR CORPORATION: COMPANY SNAPSHOT (2022) FIGURE 42 BIOCYTOGEN: COMPANY SNAPSHOT (2022) FIGURE 43 TRANS GENIC INC.: COMPANY SNAPSHOT (2023) FIGURE 44 HARBOUR BIOMED: COMPANY SNAPSHOT (2022) FIGURE 45 GENOWAY: COMPANY SNAPSHOT (2022) FIGURE 46 VIVO BIO TECH LTD: COMPANY SNAPSHOT (2022)
